Testing effectiveness (Phase 2)Study completedNCT00087685What this trial is testingRAD001 in Recurrent Endometrial Cancer PatientsWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00231855What this trial is testingEfficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) CancersWho this might be right forOvarian NeoplasmsUterine Neoplasms Montefiore Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00401635What this trial is testingEND-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinWho this might be right forEndometrial Cancer National Cancer Institute, Naples 42
Not applicableUnknownNCT06250010What this trial is testingImmunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of RecurrenceWho this might be right forEndometrial Cancer Regina Elena Cancer Institute 30
Early research (Phase 1)UnknownNCT01454479What this trial is testingA Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or CarcinosarcomaWho this might be right forRecurrent Endometrial Cancer Hung-Hsueh Chou 24
Testing effectiveness (Phase 2)Ended earlyNCT04030429What this trial is testingCrizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial CancerWho this might be right forEndometrial Cancer Recurrent National Cheng-Kung University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00334295What this trial is testingFulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.Who this might be right forEndometrial Carcinoma AstraZeneca 35
Large-scale testing (Phase 3)Ended earlyNCT00016341What this trial is testingCombination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00003439What this trial is testingInterleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerWho this might be right forCancer National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00087100What this trial is testingPemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06463028What this trial is testingSapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Faeth Therapeutics 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03835819What this trial is testingMirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)Who this might be right forEndometrial Cancer Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT05263492What this trial is testingStudy of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial CancerWho this might be right forEndometrial CancerMismatch Repair-ProficientRecurrent Endometrial Cancer Virginia Commonwealth University 4
Not applicableWithdrawnNCT05192850What this trial is testingEndometrial Cancer Recurrence in Patients Taking MetforminWho this might be right forRecurrent Endometrial Carcinoma WellSpan Health
Large-scale testing (Phase 3)Looking for participantsNCT06340568What this trial is testingA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerWho this might be right forEndometrial Cancer BioNTech SE 480
Testing effectiveness (Phase 2)Study completedNCT00377520What this trial is testingA Trial for Patients With Advanced/Recurrent Endometrial CancerWho this might be right forNeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more Eli Lilly and Company 27
Large-scale testing (Phase 3)Study completedNCT04865289What this trial is testingPembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension StudyWho this might be right forEndometrial Neoplasms Merck Sharp & Dohme LLC 130
Not applicableLooking for participantsNCT05687084What this trial is testingUterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer TrialWho this might be right forEndometrial Neoplasms Universita di Verona 1,030
Testing effectiveness (Phase 2)Ended earlyNCT03077698What this trial is testingAn Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial Cancer Xenetic Biosciences, Inc. 25